Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Receives Submissions Galore As Year Ends

Jan 07 2019

• By Bridget Silverman

Keeping Track Feature image

Related Content

AbbVie Soothes Safety Fears With More Upadacitinib RA Data

Jun 07 2018

Buoyed By Phase III Rosacea Success, Foamix Plans Commercial Transition

Nov 08 2018

Foamix's Minocycline Foam: A Game Changer In Severe Acne?

Sep 14 2018

Rheumatoid Arthritis Data Position Filgotinib Ahead Of Competition, But It's Playing Catch-Up

Sep 12 2018

Pharmaxis Faces New Study Requirement For CF Drug <em>Bronchitol</em>

Apr 16 2013

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

Oct 01 2018

Keeping Track: FDA Starts November With A Bang

Nov 02 2018

Refining A Controversial Endpoint: Sarepta Banking On Dystrophin Levels For Golodirsen Approval In DMD

Mar 13 2018

Spectrum Gears Up To File Rolontis, Stresses Patient Access

Jul 02 2018

Nabriva On Pace For Lefamulin NDA; Stock Tumbles Despite Trial Success

May 21 2018

Related Companies

AbbVie Inc.

Pfizer Inc.

Eli Lilly and Company

Incyte Corporation

Gilead Sciences, Inc.

Galapagos NV

Sarepta Therapeutics, Inc.

Vertex Pharmaceuticals Incorporated

Amgen, Inc.

Alkermes plc

Biogen, Inc.

Syntara Limited

Cornerstone Pharmaceuticals, Inc.

Vanda Pharmaceuticals, Inc.

Johnson & Johnson

Celltrion, Inc.

Samsung Bioepis Co., Ltd.

Assertio Holdings, Inc.

Mallinckrodt plc

Foamix Pharmaceuticals Ltd.

DMK Pharmaceuticals Corp.

Novartis AG

Additional Topics

United States Drug Review Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window